Showing 1 - 3 results of 3 for search 'Richard W Barker', query time: 0.04s Refine Results
  1. 1
    Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals

    Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals by Liz Morrell, Sarah Wordsworth, Anna Schuh, Mark R. Middleton, Sian Rees, Richard W. Barker

    Published 2018-05-01
    Get full text
    Article
  2. 2
    Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals

    Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals by Liz Morrell, Sarah Wordsworth, Anna Schuh, Mark R. Middleton, Sian Rees, Richard W. Barker

    Published 2019-03-01
    Get full text
    Article
  3. 3
    Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study

    Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study by Benjamin M Davies, Sarah Rikabi, Anna French, Rafael Pinedo-Villanueva, Mark E Morrey, Karolina Wartolowska, Andrew Judge, Robert E MacLaren, Anthony Mathur, David J Williams, Ivan Wall, Martin Birchall, Brock Reeve, Anthony Atala, Richard W Barker, Zhanfeng Cui, Dominic Furniss, Kim Bure, Evan Y Snyder, Jeffrey M Karp, Andrew Price, Andrew Carr, David A Brindley

    Published 2014-09-01
    Get full text
    Article

Search Tools: